Advertisement

Clinical Rheumatology

, Volume 33, Issue 11, pp 1635–1641 | Cite as

Decreased flow-mediated dilatation with increased arterial stiffness and thickness as early signs of atherosclerosis in polymyositis and dermatomyositis patients

  • Melinda VinczeEmail author
  • H. Dér
  • Gy. Kerekes
  • P. Szodoray
  • M. Zeher
  • K. Dankó
  • P. Soltész
Original Article

Abstract

Several autoimmune rheumatic diseases have been associated with accelerated atherosclerosis or other different types of vasculopathy depending on the underlying disease, leading to increased cardio- and cerebrovascular disease risk. Polymyositis (PM) and dermatomyositis (DM), members of idiopathic inflammatory myopathies (IIMs), a group of systemic autoimmune diseases are also associated with elevated risk of cardiovascular diseases (CVD). Up until now, no specific data is known on the mechanisms, risk factors, or possible vasculopathy leading to increased CVD risk. The aims of the present study were to assess the flow-mediated dilatation of the brachial artery by a TensioClinic arteriograph and to measure the thickness of carotid artery intima–media, the augmentation index, and the pulse wave velocity using high-resolution ultrasonography in a cohort of PM and DM patients. We also investigated the correlation of these parameters with the traditional risk factors of atherosclerosis and overall cardiovascular status within PM and DM patients. Twenty-seven patients (21 females, six males) with IIMs were enrolled in this study, and 38 healthy individuals matched for sex and age served as controls. We found a decreased flow-mediated dilatation in the brachial artery (6.36 vs. 8.39 %) with increased arterial stiffness and carotid artery thickness in our patients compared to healthy controls. We found significantly decreased flow-mediated dilatation of the brachial artery (5.57 vs. 8.39 %) in DM patients. We also detected a correlation between these parameters and the traditional cardiovascular risk factors, as well as hypertriglyceridemy, hypertension, and peripheral arterial disease. In DM, overall, more vascular abnormalities were found than in PM. Our findings suggest that flow-mediated dilatation of the brachial artery, arterial stiffness, and carotid artery thickness measurements could be beneficial for predicting the CVD risk in myositis patients. Further investigations need to find the potential differences and role of inflammation and immune mechanisms in atherosclerotic processes in DM and PM.

Keywords

Arterial stiffness Cardiovascular risk Dermatomyositis Endothelial dysfunction Flow-mediated vasodilatation Polymyositis 

Notes

Conflict of interest

The authors have not any conflict of interest to declare.

References

  1. 1.
    Soltész P, Kerekes G, Dér H, Szücs G, Szántó S, Kiss E, Bodolay et al. Comparative assessment of vascular function in autoimmune rheumatic diseases: considerations of prevention and treatment. Autoimmun Rev 2011 May;10(7):416–25Google Scholar
  2. 2.
    Verma S, Buchanan MR, Anderson TJ (2003) Endothelial function testing as a biomarker of vascular disease. Circulation 108(17):2054–2059PubMedCrossRefGoogle Scholar
  3. 3.
    Harris RA, Nishiyama SK, Wray DW, Richardson RS (2010) Ultrasound assessment of flow-mediated dilation. Hypertension 55(5):1075–1085PubMedCrossRefPubMedCentralGoogle Scholar
  4. 4.
    Inaba Y, Chen JA, Bergmann SR (2010) Prediction of future cardiovascular outcomes by flow-mediated vasodilatation of brachial artery: a meta-analysis. Int J Cardiovasc Imaging 26(6):631–640PubMedCrossRefGoogle Scholar
  5. 5.
    Katz SD, Hryniewicz K, Hriljac I, Balidemaj K, Dimayuga C, Hudaihed A et al (2005) Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure. Circulation 111(3):310–314PubMedCrossRefGoogle Scholar
  6. 6.
    Esdaile JM, Abrahamowicz M, Grodzicky T, Li Y, Panaritis C, du Berger R, Côte R, Grover SA, Fortin PR, Clarke AE, Senécal JL (2001) Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 44(10):2331–2337PubMedCrossRefGoogle Scholar
  7. 7.
    Zeki O, Robert Y, Oh SJ (2010) Polymyositis presenting with cardiac manifestations: report of two cases and review of the literature. Clin Neurol Neurosurg 112:160–163CrossRefGoogle Scholar
  8. 8.
    Haupt HM, Hutchins GM (1982) The heart and cardiac conduction system in polymyositis and dermatomyositis: a clinicopathologic study of autopsied patients. Am J Cardiol 50:998–1006PubMedCrossRefGoogle Scholar
  9. 9.
    Lundberg IE (2006) The heart in dermatomyositis and polymyositis. Rheumatology 45:18–21CrossRefGoogle Scholar
  10. 10.
    Eimer MJ, Brickman WJ, Seshadri R, Ramsey-Goldman R, McPherson DD, Smulevitz B et al (2011) Clinical status and cardiovascular risk profile of adults with a history of juvenile dermatomyositis. J Pediatr 159(5):795–801PubMedCrossRefPubMedCentralGoogle Scholar
  11. 11.
    Gunawardena H, Harris ND, Carmichael C, McHugh NJ (2007) Microvascular responses following digital thermal hyperaemia and iontophoresis measured by laser Doppler imaging in idiopathic inflammatory myopathy. Rheumatology (Oxford) 46(9):1483–1486CrossRefGoogle Scholar
  12. 12.
    Kerekes G, Szekanecz Z, Dér H, Sándor Z, Lakos G, Muszbek L, Csipő I, Sipka S, Seres I, Paragh G, Kappelmayer J, Szomják E, Veres K, Szegedi G, Shoenfeld Y, Soltész P (2008) Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity. J Rheumatol 35:398–406PubMedGoogle Scholar
  13. 13.
    Szücs G, Tímár O, Szekanecz Z, Dér H, Kerekes G, Szamosi S, Shoenfeld Y, Szegedi G, Soltész P (2007) Endothelial dysfunction precedes atherosclerosis in systemic sclerosis—relevance for prevention of vascular complications. Rheumatology 46:759–762PubMedCrossRefGoogle Scholar
  14. 14.
    Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE (1992) Noninvasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340:1111–1115PubMedCrossRefGoogle Scholar
  15. 15.
    Corretti MC, Anderson TJ, Benjamin EJ, Celemajer DS, Charbonneau F, Creager MA, Deanfield JE, Drexler H, Gerhard Herman M, Herrington D, Vallance P, Vita J, Vogel R, International Brachial Artery Reactivity Task Force (2002) Guidelines for the ultrasound assessment of endothelialdependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 39:257–265PubMedCrossRefGoogle Scholar
  16. 16.
    Kelm M (2002) Flow-mediated dilatation in human circulation: diagnostic and therapeutic aspects. Am J Physiol Heart Circ Physiol 282:1–5Google Scholar
  17. 17.
    Kanters SDJM, Algra A, van Leeuwen MS, Banga JD (1997) Reproducibility of in vivo carotid intima–media thickness measurements. Stroke 28:665–671PubMedCrossRefGoogle Scholar
  18. 18.
    Baulmann J, Schillings U, Rickert S, Uen S, Düsing R, Cziraki A, Illyes M, Mengden T (2008) A new oscillometric method for assessment of arterial stiffness: comparison with tonometric and piezo-electronic methods. J Hypertens 26:523–528PubMedCrossRefGoogle Scholar
  19. 19.
    Magometschnigg D (2005) Blood pressure and arterial stiffness. A comparison of two devices for measuring augmentation index and pulse wave velocity. Wien Med Wochenschr 155:404–410PubMedCrossRefGoogle Scholar
  20. 20.
    Mercanoglu F, Erdogan D, Oflaz H, Kücükkaya R, Selcukbiricik F, Gül A et al (2004) Impaired brachial endothelial function in patients with primary anti-phospholipid syndrome. Int J Clin Pract 58(11):1003–1007PubMedCrossRefGoogle Scholar
  21. 21.
    Cugno M, Borghi MO, Lonati LM, Ghiadoni L, Gerosa M, Grossi C et al (2010) Patients with antiphospholipid syndrome display endothelial perturbation. J Autoimmun 34(2):105–110PubMedCrossRefGoogle Scholar
  22. 22.
    Mosca M, Virdis A, Tani C, Ghiadoni L, Versari D, Duranti E et al (2009) Vascular reactivity in patients with undifferentiated connective tissue diseases. Atherosclerosis 203(1):185–191PubMedCrossRefGoogle Scholar
  23. 23.
    Soltesz P, Bereczki D, Szodoray P, Magyar MT, Der H, Csipo I et al (2010) Endothelial cell markers reflecting endothelial celldysfunction in patients with mixed connective tissue disease. Arthritis Res Ther 12(3):R78PubMedCrossRefPubMedCentralGoogle Scholar
  24. 24.
    Chatterjee Adhikari M, Guin A, Chakraborty S, Sinhamahapatra P, Ghosh A (2012) Subclinical atherosclerosis and endothelial dysfunction in patients with early rheumatoid arthritis as evidenced by measurement of carotid intima-media thickness and flow-mediated vasodilatation: an observational study. Semin Arthritis Rheum 41(5):669–675PubMedCrossRefGoogle Scholar
  25. 25.
    Au K, Singh MK, Bodukam V, Bae S, Maranian P, Ogawa R, Spiegel B et al (2011) Atherosclerosis in systemic sclerosis: a systematic review and meta-analysis. Arthritis Rheum 63(7):2078–2090PubMedCrossRefPubMedCentralGoogle Scholar
  26. 26.
    Filer AD, Gardner-Medwin JM, Thambyrajah J, Raza K, Carruthers DM, Stevens RJ et al (2003) Diffuse endothelial dysfunction is common to ANCA associated systemic vasculitis and polyarteritis nodosa. Ann Rheum Dis 62(2):162–167PubMedCrossRefPubMedCentralGoogle Scholar
  27. 27.
    Kerekes G, Bodolay E, Sipka S, Szomják E, Veres K, Zeher M et al (2005) Endothelial dysfunction and early atherosclerosis in non-differentiated collagenosis. Orv Hetil 146(17):791–795PubMedGoogle Scholar
  28. 28.
    Soltesz P, Der H, Veres K, Laczik R, Sipka S, Szegedi G, Szodoray P (2008) Immunological features of primary antiphospholipid syndrome in connection with endothelial dysfunction. Rheumatology (Oxford) 47:1628–1634CrossRefGoogle Scholar
  29. 29.
    Soltész P, Dér H, Kerekes G, Szodoray P, Szücs G, Dankó K, Shoenfeld Y, Szegedi G, Szekanecz Z (2009) A comparative study of arterial stiffness, flow-mediated vasodilation of the brachial artery, and the thickness of the carotid artery intima-media in patients with systemic autoimmune diseases. Clin Rheumatol 28(6):655–662. doi: 10.1007/s10067-009-1118-y, Epub 2009 Feb 18PubMedCrossRefGoogle Scholar

Copyright information

© Clinical Rheumatology 2014

Authors and Affiliations

  • Melinda Vincze
    • 1
    Email author
  • H. Dér
    • 2
  • Gy. Kerekes
    • 2
  • P. Szodoray
    • 3
  • M. Zeher
    • 1
  • K. Dankó
    • 1
  • P. Soltész
    • 2
  1. 1.Division of Clinical Immunology, Department of Internal MedicineUniversity of DebrecenDebrecenHungary
  2. 2.Division of Angiology, Department of Internal MedicineUniversity of DebrecenDebrecenHungary
  3. 3.Institute of Immunology, RikshospitaletOslo University HospitalOsloNorway

Personalised recommendations